Concepedia

Author

Jan Muilwijk

National Institute for Public Health and the Environment

Also Known As

J. C. Monen, J. Monen, J. Muilwijk, Jan Muilwijk, Muilwijk, Jan

44

Publications

382

Citations

8

H-Index

15

Concepts

All Affiliations

National Institute for Public Health and the EnvironmentDutch Institute for Healthcare ImprovementAmsterdam UMC Location University of AmsterdamTuBerculosis Vaccine InitiativeBronovo Hospital
JM

About

Jan Muilwijk is an author at National Institute for Public Health and the Environment specializing in medicine, epidemiology, and outcomes research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

91

2

Public Health

1

1

55

3

Epidemiology

1

1

55

4

Microbiology

1

1

36

5

Orthopaedics

1

1

55

Jan Muilwijk

×

6

Publications

292

Citations

6

H-Index

YearCitations

Associations Between Surgical Site Infection Risk and Hospital Operation Volume and Surgeon Operation Volume Among Hospitals in the Dutch Nosocomial Infection Surveillance Network

Jan Muilwijk, Susan van den Hof, J. Wille

Infection Control and Hospital Epidemiology

2007

84

Random effect modelling of patient-related risk factors in orthopaedic procedures: results from the Dutch nosocomial infection surveillance network ‘PREZIES’

Jan Muilwijk, Geert H.I.M. Walenkamp, J. Wille,

Journal of Hospital Infection

2006

55

Trends in the Incidence of Surgical Site Infection in The Netherlands

Judith Manniën, Susan van den Hof, Jan Muilwijk,

Infection Control and Hospital Epidemiology

2008

53

Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands

Maike Koningstein, Akke K. van der Bij, Marlieke E.A. de Kraker,

PLoS ONE

2014

42

Clinical breakpoint changes and their impact on surveillance of antimicrobial resistance in Escherichia coli causing bacteraemia

Akke K. van der Bij, Karin van Dijk, Jan Muilwijk,

Clinical Microbiology and Infection

2012

36

Consequences of switching from a fixed 2 : 1 ratio of amoxicillin/clavulanate (CLSI) to a fixed concentration of clavulanate (EUCAST) for susceptibility testing of Escherichia coli

Maurine A. Leverstein‐van Hall, K. Waar, Jan Muilwijk,

Journal of Antimicrobial Chemotherapy

2013

22

Page 1